Laue Hannah E, Coker Modupe O, Madan Juliette C
Department of Epidemiology, Geisel School of Medicine at Dartmouth, Hanover, NH, United States.
Rutgers School of Dental Medicine, The State University of New Jersey, Newark, NJ, United States.
Front Pediatr. 2022 Mar 7;10:815885. doi: 10.3389/fped.2022.815885. eCollection 2022.
The volume and breadth of research on the role of the microbiome in neurodevelopmental and neuropsychiatric disorders has expanded greatly over the last decade, opening doors to new models of mechanisms of the gut-brain axis and therapeutic interventions to reduce the burden of these outcomes. Studies have highlighted the window of birth to 3 years as an especially sensitive window when interventions may be the most effective. Harnessing the powerful gut-brain axis during this critical developmental window clarifies important investigations into the microbe-human connection and the developing brain, affording opportunities to prevent rather than treat neurodevelopmental disorders and neuropsychiatric illness. In this review, we present an overview of the developing intestinal microbiome in the critical window of birth to age 3; and its prospective relationship with neurodevelopment, with particular emphasis on immunological mechanisms. Next, the role of the microbiome in neurobehavioral outcomes (such as autism, anxiety, and attention-deficit hyperactivity disorder) as well as cognitive development are described. In these sections, we highlight the importance of pairing mechanistic studies in murine models with large scale epidemiological studies that aim to clarify the typical health promoting microbiome in early life across varied populations in comparison to dysbiosis. The microbiome is an important focus in human studies because it is so readily alterable with simple interventions, and we briefly outline what is known about microbiome targeted interventions in neurodevelopmental outcomes. More novel examinations of known environmental chemicals that adversely impact neurodevelopmental outcomes and the potential role of the microbiome as a mediator or modifier are discussed. Finally, we look to the future and emphasize the need for additional research to identify populations that are sensitive to alterations in their gut microbiome and clarify how interventions might correct and optimize neurodevelopmental outcomes.
在过去十年中,关于微生物群在神经发育和神经精神疾病中作用的研究数量和广度大幅扩展,为肠-脑轴机制的新模型以及减轻这些疾病负担的治疗干预措施打开了大门。研究强调,从出生到3岁是一个特别敏感的时期,此时进行干预可能最为有效。在这个关键的发育时期利用强大的肠-脑轴,有助于对微生物与人类的联系以及发育中的大脑进行重要研究,从而提供预防而非治疗神经发育障碍和神经精神疾病的机会。在这篇综述中,我们概述了从出生到3岁这一关键时期肠道微生物群的发育情况;及其与神经发育的潜在关系,特别强调免疫机制。接下来,将描述微生物群在神经行为结果(如自闭症、焦虑症和注意力缺陷多动障碍)以及认知发展中的作用。在这些部分中,我们强调将小鼠模型中的机制研究与大规模流行病学研究相结合的重要性,后者旨在阐明与生态失调相比,不同人群早期促进健康的典型微生物群。微生物群是人类研究的一个重要焦点,因为它很容易通过简单的干预措施改变,我们简要概述了针对神经发育结果的微生物群靶向干预措施的已知情况。还将讨论对已知会对神经发育结果产生不利影响的环境化学物质的更新颖研究,以及微生物群作为介质或调节剂的潜在作用。最后,我们展望未来,强调需要进行更多研究,以确定对肠道微生物群变化敏感的人群,并阐明干预措施如何纠正和优化神经发育结果。